Funguria in Hospitalized Patients

This study is ongoing, but not recruiting participants.

First Received: August 26, 2005 Last Updated: December 19, 2007 History of Changes

Sponsored by:	National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by:	National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:	NCT00138502

Purpose

The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.

Condition
Candidiasis

MedlinePlus related topics: Yeast Infections

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	The Significance of Funguria In Hospitalized Patients

Further study details as provided by National Institute of Allergy and Infectious Diseases (NIAID):

Estimated Enrollment:	926
Study Start Date:	September 2001
Estimated Study Completion Date:	April 2005

Detailed Description:

This protocol will attempt to generate a detailed clinical profile of patients with funguria and identify subgroups of patients with funguria at high risk for candiduria and determine the relative risks for obtaining candiduria. In addition, it will look at identifying subgroups of patients with funguria at high risk for candidemia and identifying subgroups of patients with funguria at high risk for death. Finally, it will attempt to determine if funguria independently predicts fungemia or death. Data will be complemented by surveillance of a comparable population without funguria.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Subjects with fungi isolated from the urine of any colony count.
Patients seen at either Harbor-UCLA Medical Center or Cedars Sinai Medical Center.

Exclusion Criteria:

1. Persons with a previously positive urine fungal culture during the current hospital admission.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00138502

Locations

United States, California
UCLA Center For Vaccine Research
Torrence, California, United States, 90509
Cedars Sinai Medical Center
Los Angeles, California, United States, 90048

Sponsors and Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

More Information

No publications provided

Study ID Numbers:	02-050
Study First Received:	August 26, 2005
Last Updated:	December 19, 2007
ClinicalTrials.gov Identifier:	NCT00138502 History of Changes
Health Authority:	Unspecified

Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID):

Candidiasis, Funguria

Study placed in the following topic categories:

Mycoses
Candidiasis

Additional relevant MeSH terms:

Mycoses
Candidiasis

ClinicalTrials.gov processed this record on May 07, 2009